Abstract:Cardiovascular disease stands as the leading cause of death globally, claiming approximately 19 million lives in 2020. On the contrary, the development of cardiovascular drugs is experiencing a decline, largely due to the bottleneck in understanding the pathophysiology of various heart diseases and assessing the effects of drugs on healthy human hearts. The development of induced pluripotent stem cell (iPSC) technology and the availability of cardiac cell types in vitro, has resulted in a surge in efforts to fabricate human cardiac models for disease modelling and drug discovery applications. Although numerous attempts evidence successful fabrication of 3 dimensional (3D) engineered heart tissues, the innate immune cell population of the myocardium ;particularly cardiac macrophages, was until recently, overlooked. With increasing appreciation of the interactions between cardiomyocytes and macrophages in the myocardium, in this work, isogenic populations of cardiac resident-like macrophages and cardiomyocytes were generated using iPSCs, to understand the interactions between the two cell types in both 2D and 3D settings, and subjected to electric stimulation. After characterizing iPSC-derived macrophages (iMacs) and iPSC-derived cardiomyocytes (iCMs) in depth, the conditioning of iMacs to align to a cardiac resident macrophage-like phenotype in the presence of iCMs in 2D culture was explored. In coculture with iCMs, iMacs upregulated known genes expressed by cardiac resident macrophages. Additionally, in co-culture with iMacs, iCMs displayed an elongated morphology, improved calcium function and an increase in known maturation genes such as the ratio between MYH7 and MYH6 as well as SERCA2. In a 2D setting, iMacs showed the ability to electrically couple with iCMs and facilitate synchronous beating in iCM cultures. The 2D characterisation was translated into an engineered cardiac tissue model, wherein, improvement in tissue characteristics in the presence of iMacs was demonstrated in terms of increased cell alignment, enhanced cardiomyocyte elongation, physiologically relevant beat rates and improved tissue compaction. Taken together, these findings may open new avenues to use iMacs in engineered cardiac tissue models, not only as an innate immune cell source, but also as a support cell type to improve cardiomyocyte function and maturation.

Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Induced Pluripotent Stem Cells As a Disease Modeling and Drug Screening Platform

Differentiation of Human-Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics

Induced Pluripotent Stem Cells: Ex Vivo Models for Human Diseases Due to Mitochondrial DNA Mutations

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Patient-specific Induced Pluripotent Stem Cell Models in Mitochondrial Diseases.

Synergistic generation of cardiac resident-like macrophages and cardiomyocyte maturation in tissue engineered platforms

A Comparative Study of Human Pluripotent Stem Cell-Derived Macrophages in Modeling Viral Infections

[Induction and Differentiation of Induced Pluripotent Stem Cells into Macrophages: a Review].

hiPSC-derived macrophages improve drug sensitivity and selectivity in a macrophage-incorporating organoid culture model

Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening

Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages

Human iPSC-Derived Proinflammatory Macrophages cause Insulin Resistance in an Isogenic White Adipose Tissue Microphysiological System

Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses

Synergy Between Pluripotent Stem Cell-Derived Macrophages and Self-Renewing Macrophages: Envisioning a Promising Avenue for the Modelling and Cell Therapy of Infectious Diseases.

Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications

The in silico macrophage: toward a better understanding of inflammatory disease

Approaches for studying human macrophages

Human pluripotent stem cell (hPSC)-derived microglia for the study of brain disorders. A comprehensive review of existing protocols.

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications